Thus, the role of BRCA1 upon estrogen challenges exceed the HR mechanism, which is also supported by different mutational processes revealed by distinct patterns of genomic imprints born by BRCA1 and BRCA2-mutated cancers [22]. This evidence concerns the gene BRCA2 and cancer.